Ex­clu­sive: ‘Chat­G­PT for DNA’: Re­la­tion nabs $35M, with Nvidia back­ing, for os­teo­poro­sis work

The ven­ture arm of Nvidia, the su­per­com­put­ing gi­ant ris­ing up the world’s most valu­able com­pa­nies chart, is back­ing a com­pu­ta­tion­al drug dis­cov­ery start­up that’s head­ed to­ward the clin­ic for os­teo­poro­sis, a large field with few in­no­va­tions.

Re­la­tion Ther­a­peu­tics has added $35 mil­lion to its cof­fers, the com­pa­ny ex­clu­sive­ly told End­points News. Nvidia’s NVen­tures, DCVC, Deer­field Man­age­ment Com­pa­ny, Khosla Ven­tures, Ab­cam founder Jonathan Mil­ner, ARK In­vest and Mag­net­ic Ven­tures con­tributed funds, which bring the to­tal seed fi­nanc­ing to $60 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER